Our content is moving! Please follow @EdelmanPR for all future updates and thought leadership from us at Edelman’s Public and Government Affairs practice.
US Congress is ramping up scrutiny of Chinese biotech. What does this mean for biotech policy in the US? Read our Quick Take to learn more. https://t.co/VfeG9BZT8M
#China#Politics#Biotech
Read our synopsis of what is happening in #Colombia amid the attorney general election. #https://www.edelmanglobaladvisory.com/institutions-are-resilient-amid-chaotic-colombian-attorney-general-election
Happy Lunar New Year from EGA🎉🐉
As we usher in the Year of the Dragon, we reflect on the power of global communications to connect us, bridge cultures, and ignite new beginnings. We extend our warmest wishes to our partners, clients, and colleagues around the world.
What do the heightened security risks from the Houthi attacks on commercial ships in the Red Sea mean for the global economy? Read our Quick Take to learn more about the potential impacts. #geopolitics https://t.co/vKAw1NoKRr
Do you have a passion for health and life science? EGA Brussels is hiring! If you have experience in political science, public affairs or #health policy law, visit the link below to learn more and apply. https://t.co/U7OGNXxftJ
BREAKING NEWS🚨Florida Governor Ron DeSantis suspended his campaign over the weekend, endorsing former President Donald Trump. How will this impact the rest of the GOP race? Read our insights on and what it means for tomorrow’s New Hampshire primary here: https://t.co/GPL97JFcZQ
The FDA authorized Florida to import prescription drugs directly from Canada for public health insurance programs. Read our insights on how this will impact the industry and what they will need to do to navigate political discourse on drug pricing. https://t.co/oTuFc1HKam
Over 110,000 people participated in the Iowa Republican Caucus, where the GOP candidates made their case for nomination. For a recap on candidate standings, key issues, and what’s coming up next in the 2024 US #election cycle, read our key findings: https://t.co/kx2CAlsmI1
@DPPonline's @ChingteLai is Taiwan’s new president, winning just over 40% of the vote. Despite the win, the Lai-DPP is far from a mandate. Read more about global reactions, Lai policy priorities and what it means for businesses: https://t.co/i6G0YxSBFp
#TaiwanElection2024
In case you missed it, be sure to also read our election primer on the parties and candidates, and what we’re watching heading into the elections: https://t.co/eBQVx0pKlY #Taiwan#elections
Taiwan heads to the polls tomorrow to elect a new president—with implications for regional stability and global trade. Markets have wide ranging views on the political and economic relationships between China, Taiwan, and the U.S. so global companies should be watching.
.@wes_ball spoke on a panel for @instituteforgov on how opposition parties in the UK should prepare to take the reins of government should they win the election.
The panel was centered around @instituteforgov’s recent report titled, “Preparing for government: How the official opposition should ready itself for power”. @wes_ball brought his expertise as former Director of the Parliamentary Labour Party to this panel.
As we head into the holidays, here's our roundup of major #geopolitical events that will be approaching in the New Year—from #elections to #shipping issues—that we are encouraging clients to keep an eye on for potential risk. Here's what you need to know:
https://t.co/ylaTsPYSoc
It was the 2019-20 holiday season when an unknown “pneumonia” first started appearing in Wuhan, China & the 2021-22 season was when Russia escalated its build-up of troops on the Ukraine border—both reminders that geopolitics don't stop for holidays. https://t.co/ylaTsPYSoc
Read our latest quick take by Joseph Damond, EGA Health Chair for background on the new rules, how they could be enacted, and where there is opportunity for stakeholders to shape the final regulations: https://t.co/sMBgcIS9Hk
In #healthcare, a delicate balance exists between innovation & patient access to life-saving medicines. The Biden admin recently announced plans for new rules on seizing #patents from #pharma companies for drugs that received publicly financed research. https://t.co/sMBgcIS9Hk